Clinical Significance, Species Distribution, and Temporal Trends of Nontuberculous Mycobacteria, Denmark, 1991–2022
Victor Naestholt Dahl
, Andreas Arnholdt Pedersen, Anders Norman, E. Michael Rasmussen, Jakko van Ingen, Aase Bengaard Andersen, Christian Morberg Wejse
1, and Troels Lillebaek
1
Author affiliations: Statens Serum Institut, Copenhagen, Denmark (V.N. Dahl, A. Norman, E.M. Rasmussen, T. Lillebaek); Aarhus University Hospital, Aarhus, Denmark (V.N. Dahl, C.M. Wejse); Aarhus University, Aarhus (V.N. Dahl, C.M. Wejse); Odense University Hospital, Odense, Denmark (A.A. Pedersen); Lillebaelt Hospital, Vejle, Denmark (A.A. Pedersen); Radboud University Medical Center, Nijmegen, the Netherlands (J. van Ingen); Rigshospitalet, Copenhagen (A.B. Andersen); University of Copenhagen, Copenhagen (T. Lillebaek)
Main Article
Figure 2
Figure 2. Annual incidence rates (infections/100,000 persons) of unique patients with a first culture positive for nontuberculous mycobacteria, by disease localization (A) and disease category for patients with pulmonary isolates only (B), Denmark, 1991–2022. Patients with samples from both pulmonary and extrapulmonary locations were categorized as having disseminated disease.
Main Article
Page created: July 08, 2024
Page updated: August 20, 2024
Page reviewed: August 20, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.